GRTS News and Press, Gritstone Oncology Inc. From 09/27/23

2023-09-27 16:26:15 ET More on Gritstone bio Gritstone bio (GRTS) Investor Presentation - Slideshow Gritstone: Trying To Pick Itself Up From The COVID Ruins Seeking Alpha’s Quant Rating on Gritstone bio Historical earnings data for Gritstone bio ...

-- 10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus other viral targets with an approved vaccine against COVID-19 -- -- Contract is part of ‘Project NextGen,’ an initiative by the ...

Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of infectious disease vaccines Multi-year, multi-pathogen, option-based deal follows multiple successful prior collabora...

2023-08-09 17:32:16 ET Gritstone bio press release ( NASDAQ: GRTS ): Q2 GAAP EPS of -$0.31 beats by $0.05 . Revenue of $1.96M (-64.2% Y/Y) misses by $0.51M . For further details see: Gritstone bio GAAP EPS of -$0.31 beats by $0.05, revenue of $1.96M misse...

-- Enrollment completed in Phase 2 portion of Phase 2/3 study evaluating GRANITE (personalized cancer vaccine [PCV]) in first-line metastatic microsatellite-stable colorectal cancer (MSS-CRC); preliminary efficacy data expected in 1Q 2024 -- -- Gritstone partnering with Friends of Cance...

EMERYVILLE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company has joined the ctMoniTR Project , a collaborative research initiative...

2023-08-01 03:09:04 ET Summary Gritstone bio flew high during the COVID years because of its mRNA COVID vaccine program. With COVID down, GRTS stock has also gone down. Now it survives on its legacy oncology programs, which have some promise. Gritstone bio, Inc. ( ...

2023-07-21 17:17:13 ET Gainers: Gritstone bio ( GRTS ) +4.8% . LexinFintech Holdings ( LX ) +4.3% . AppLovin ( APP ) +2.9% . Latham Group ( SWIM ) +2.6% . Accuray ( ARAY ) +2.5% . Losers: ALX Oncology Holdings ( ALXO ...

-- Potent and durable immunogenicity achieved with low dose self-amplifying mRNA vaccine (samRNA) candidate -- -- Immunity boosted for at least 6 months in previously vaccinated-older adults (administration post-primary series of Vaxzevria ® , Comirnaty ® or Spikevax ...

2023-05-12 12:06:28 ET Gritstone bio ( NASDAQ: GRTS ) stock fell ~10% on Friday after Q1 revenue missed estimates. Net loss widened to -$33.98M, compared to -$28.92M in Q1 2022. Total revenues fell -66% Y/Y to $2.44M. Collaboration and license revenues decline...